Gainers
- Prana Biotechnology Limited (NASDAQ:PRAN) shares jumped 53.2 percent to $1.9602 after the company entered a Securities Purchase Agreement with Life Biosciences. Life Biosciences is set to invest up to $44.5 million in Prana Biotechnology.
- MedEquities Realty Trust, Inc. (NYSE:MRT) gained 43.7 percent to $9.83 after Omega Healthcare Investors, Inc. (NYSE:OHI) announced plans to acquire MedEquities Realty Trust in a transaction representing enterprise value of approximately $600 million.
- Renmin Tianli Group Inc (NASDAQ:ABAC) gained 33.3 percent to $1.24 after the company entered into a purchase agreement to acquire a portfolio of industrial and residential properties.
- Marin Software Incorporated (NASDAQ:MRIN) shares rose 22 percent to $6.48.
- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) surged 21.1 percent to $2.87.
- DLH Holdings Corp. (NASDAQ:DLHC) shares rose 20.7 percent to $5.71.
- Bright Scholar Education Holdings Limited (NYSE:BEDU) shares jumped 19.1 percent to $10.97.
- Windstream Holdings Inc (NASDAQ:WIN) gained 18.2 percent to $2.47 after the company reported the sale of EarthLink consumer internet business for $330 million in cash.
- Genocea Biosciences Inc (NASDAQ:GNCA) climbed 16.8 percent to $0.3350 after the company announced it dosed its first patients and completed enrollment in Part A of Phase 1/2a in the clinical trial for the neoantigen vaccine candidate, GEN-009.
- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) climbed 16.7 percent to $0.7000.
- NF Energy Saving Corporation (NASDAQ:NFEC) gained 15.8 percent to $18.22.
- Harte Hanks, Inc. (NYSE:HHS) shares rose 15.7 percent to $2.80.
- Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) jumped 14.5 percent to $2.69.
- Iterum Therapeutics plc (NASDAQ:ITRM) shares gained 14.5 percent to $5.73.
- GSE Systems, Inc. (NASDAQ:GVP) shares rose 14.3 percent to $2.40.
- Centrais Elétricas Brasileiras S.A. - Eletrobras (NYSE:EBR) climbed 13.7 percent to $7.22.
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) gained 13.1 percent to $6.16. Allena Pharmaceuticals achieved alignment with the FDA on Phase 3 program and accelerated approval pathway for reloxaliase in enteric hyperoxaluria.
- scPharmaceuticals Inc. (NASDAQ:SCPH) gained 12 percent to $4.21.
- Eldorado Gold Corporation (NYSE:EGO) rose 11.1 percent to $3.20.
- Nuverra Environmental Solutions, Inc. (NYSE:NES) surged 11 percent to $9.10.
- Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) rose 10.4 percent to $4.4285.
- ProQR Therapeutics N.V. (NASDAQ:PRQR) gained 10 percent to $17.35 after the company received Fast Track Destination from the FDA for QR-421a.
- Ballard Power Systems Inc. (NASDAQ:BLDP) shares jumped 8.8 percent to $2.60.
- Cara Therapeutics, Inc. (NASDAQ:CARA) shares gained 8.3 percent to $14.08 after the company completed interim analysis of its pivotal phase 3 KALM-1 trial and announced no modifications to patient size.
- Bausch Health Companies Inc. (NYSE:BHC) rose 6.1 percent to $19.59 after Piper Jaffray upgraded the company's stock to Overweight with a $27 price target.
Check out these big penny stock gainers and losers
Losers
- Pingtan Marine Enterprise Ltd. (NASDAQ:PME) shares dipped 18.1 percent to $2.09.
- Bitauto Holdings Limited (NYSE:BITA) shares dropped 18 percent to $20.32 after surging 9.07 percent on Monday.
- Performant Financial Corporation (NASDAQ:PFMT) fell 17.3 percent to $1.86.
- Uxin Limited (NASDAQ:UXIN) shares declined 17.1 percent to $4.03.
- Yangtze River Port and Logistics Limited (NASDAQ:YRIV) fell 14 percent to $3.39.
- Hexindai Inc. (NASDAQ:HX) shares fell 11.6 percent to $2.21.
- Lincoln Educational Services Corporation (NASDAQ:LINC) dipped 11 percent to $2.85.
- MyoKardia, Inc. (NASDAQ:MYOK) dropped 10 percent to $43.98 after the company announced its collaboration with Sanofi ended and it regained rights to Mavacamten and MYK-19.
- James Hardie Industries plc (NYSE:JHX) shares slipped 9.4 percent to $10.64.
- Travelzoo (NASDAQ:TZOO) shares fell 9.4 percent to $8.91.
- Kewaunee Scientific Corporation (NASDAQ:KEQU) dropped 8.9 percent to $30.29.
- Cryoport, Inc. (NASDAQ:CYRX) shares tumbled 8.6 percent to $10.09.
- Tesla, Inc. (NASDAQ:TSLA) dropped 8.2 percent to $305.61 after the company's Q4 vehicle delivery numbers failed to meet estimates.
- Tyme Technologies, Inc. (NASDAQ:TYME) dropped 8.1 percent to $3.3925 after the company announced it is offering to sell 12.09 million common shares.
- iPic Entertainment Inc. (NASDAQ:IPIC) shares fell 7.8 percent to $2.8944.
- Globus Medical, Inc. (NYSE:GMED) tumbled 7.5 percent to $40.03 after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered the price target from $64 to $49.
- Hologic, Inc. (NASDAQ:HOLX) dropped 6.6 percent to $38.40. Morgan Stanley downgraded Hologic from Equal-Weight to Underweight.
- Louisiana-Pacific Corporation (NYSE:LPX) dropped 5.6 percent to $20.97 after Bank of America downgraded the stock from Buy to Neutral and lowered the price target from $29 to $24.
- CyrusOne Inc. (NASDAQ:CONE) declined 5.5 percent to $49.95 after Bank of America downgraded the stock from Buy to Neutral.
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) dipped 5.1 percent to $41.28 after Raymond James downgraded the stock from Market Outperform to Market Perform.
BHCBausch Health Companies Inc
$6.930.29%
BLDPBallard Power Systems Inc
$2.61-1.68%
CYRXCryoPort Inc
$9.24-%
DLHCDLH Holdings Corp
$5.660.18%
EGOEldorado Gold Corp
$34.41-%
GMEDGlobus Medical Inc
$85.79-%
HHSHarte-Hanks Inc
$2.87-10.9%
HOLXHologic Inc
$75.02-%
IPICIPic Entertainment Inc
$0.00010-%
ITRMIterum Therapeutics PLC
$0.41082.19%
JHXJames Hardie Industries PLC
$20.09-0.94%
KEQUKewaunee Scientific Corp
$38.49-%
LINCLincoln Educational Services Corp
$23.21-%
LPXLouisiana-Pacific Corp
$84.44-%
MRTMarti Technologies Inc
$2.40-%
OHIOmega Healthcare Investors Inc
$44.550.79%
PESIPerma-Fix Environmental Services Inc
$13.62-%
PRQRProQR Therapeutics NV
$2.27-%
RAREUltragenyx Pharmaceutical Inc
$34.400.17%
TSLATesla Inc
$490.570.14%
TZOOTravelzoo
$7.46-%
UXINUxin Ltd
$2.722.26%
YRIVYangtze River Port and Logistics Ltd
$0.00020-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
